The Associated Press TRENTON, N.J.
Food and Drug Administration advisers have voted to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk . e
Th FDA will determine what new label wording will say.
A few patients have suffered serious complications, including jawbone destruction and unusual thighbone fractures, generally after several years taking the drugs.
The drugs stop and reverse dangerous thinning of bones in many people, preventing hip and spine fractures.
But after a while, it’s unclear whether they do more harm than good. So experts have been reviewing data to try to provide better advice on whether patients should stop the drugs totally or temporarily after several years.